132 related articles for article (PubMed ID: 2188980)
1. Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli.
Reilly TM; Seetharam R; Duke JL; Davis GL; Pierce SK; Walton HL; Kingsley D; Sisk WP
J Biol Chem; 1990 Jun; 265(16):9570-4. PubMed ID: 2188980
[TBL] [Abstract][Full Text] [Related]
2. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
Lawrence D; Strandberg L; Grundström T; Ny T
Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
[TBL] [Abstract][Full Text] [Related]
3. Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin.
Wun TC; Palmier MO; Siegel NR; Smith CE
J Biol Chem; 1989 May; 264(14):7862-8. PubMed ID: 2470735
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterisation of plasminogen activator inhibitor 2 produced in Saccharomyces cerevisiae.
Steven J; Cottingham IR; Berry SJ; Chinery SA; Goodey AR; Courtney M; Ballance DJ
Eur J Biochem; 1991 Mar; 196(2):431-8. PubMed ID: 1901039
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of active and latent forms of recombinant plasminogen activator inhibitor 1 produced in Escherichia coli.
Seetharam R; Dwivedi AM; Duke JL; Hayman AC; Walton HL; Huckins NR; Kamerkar SM; Corman JI; Woodeshick RW; Wilk RR
Biochemistry; 1992 Oct; 31(41):9877-82. PubMed ID: 1382596
[TBL] [Abstract][Full Text] [Related]
6. Structural determinants of the noncatalytic chain of tissue-type plasminogen activator that modulate its association rate with plasminogen activator inhibitor-1.
de Serrano VS; Castellino FJ
J Biol Chem; 1990 Jun; 265(18):10473-8. PubMed ID: 2113057
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
Andreasen PA; Nielsen LS; Kristensen P; Grøndahl-Hansen J; Skriver L; Danø K
J Biol Chem; 1986 Jun; 261(17):7644-51. PubMed ID: 3086313
[TBL] [Abstract][Full Text] [Related]
8. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
Hekman CM; Loskutoff DJ
Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
[TBL] [Abstract][Full Text] [Related]
9. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.
Preissner KT; Grulich-Henn J; Ehrlich HJ; Declerck P; Justus C; Collen D; Pannekoek H; Müller-Berghaus G
J Biol Chem; 1990 Oct; 265(30):18490-8. PubMed ID: 1698787
[TBL] [Abstract][Full Text] [Related]
10. Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned medium.
Lindahl T; Wiman B
Biochim Biophys Acta; 1989 Feb; 994(3):253-7. PubMed ID: 2493266
[TBL] [Abstract][Full Text] [Related]
11. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
[TBL] [Abstract][Full Text] [Related]
12. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
Ballance DJ; Marshall JM; Cottingham IR; Steven J; Berry SJ; Cederholm-Williams SA; Goodey AR; Courtney M
Eur J Biochem; 1992 Jul; 207(1):177-83. PubMed ID: 1321039
[TBL] [Abstract][Full Text] [Related]
13. An inhibitor of plasminogen activation from human placenta. Purification and characterization.
Wun TC; Reich E
J Biol Chem; 1987 Mar; 262(8):3646-53. PubMed ID: 3102492
[TBL] [Abstract][Full Text] [Related]
14. Reactivated recombinant plasminogen activator inhibitor-1 (rPAI-1) effectively prevents thrombolysis in vivo.
Vaughan DE; Declerck PJ; Van Houtte E; De Mol M; Collen D
Thromb Haemost; 1992 Jul; 68(1):60-3. PubMed ID: 1514173
[TBL] [Abstract][Full Text] [Related]
15. On the reversible interaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator and with urokinase-type plasminogen activator.
Lijnen HR; Van Hoef B; Collen D
J Biol Chem; 1991 Mar; 266(7):4041-4. PubMed ID: 1900284
[TBL] [Abstract][Full Text] [Related]
16. Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1.
Franke AE; Danley DE; Kaczmarek FS; Hawrylik SJ; Gerard RD; Lee SE; Geoghegan KF
Biochim Biophys Acta; 1990 Jan; 1037(1):16-23. PubMed ID: 2403813
[TBL] [Abstract][Full Text] [Related]
17. Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies.
Lee HJ; Im H
Protein Expr Purif; 2003 Sep; 31(1):99-107. PubMed ID: 12963346
[TBL] [Abstract][Full Text] [Related]
18. Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.
Wagner OF; Vetterlein M; Binder BR
J Biol Chem; 1986 Nov; 261(31):14474-81. PubMed ID: 3490474
[TBL] [Abstract][Full Text] [Related]
19. Purification of epidermal plasminogen activator inhibitor.
Hibino T; Izaki S; Izaki M
FEBS Lett; 1986 Nov; 208(2):273-7. PubMed ID: 3096778
[TBL] [Abstract][Full Text] [Related]
20. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.
Hekman CM; Loskutoff DJ
J Biol Chem; 1985 Sep; 260(21):11581-7. PubMed ID: 3930479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]